Expertise in Precision Medicine
The Personalized Health Care Committee presents resources which focus on emerging areas of precision medicine. This includes brief, relevant articles by CAP members that enable the reader to gain a better understanding of a particular area of precision medicine. Examples include pharmacogenetics, immune response genes, and the latest in the molecular drivers of cancer. Articles often include curated references so readers may learn more about a particular subject area.
We hope you find these resources useful, and if you have ideas for topics you would like to learn more about please do not hesitate to email us.
Articles and Presentations by the Personalized Health Care Committee
The following articles and presentation were developed by members of the Personalized Health Care Committee and cover a variety of precision medicine topics.
- The Expanding Role of Cell-Free DNA in Transfusion Medicine; Pearl Audon, DO, Gagan Mathur, MD, MBA, CPE, FCAP, April 22, 2026
- Mismatches in Mismatch Repair: Navigating Discordant MMR/MSI Test Results; Jeremy D. Ward, MD, PhD, FCAP, Matthew Hiemenz, MD, MS, FCAP, March 30, 2026
- Utilizing Cell-Free DNA Technologies for Clinically Significant Biomarkers in Solid Organ Transplantation; Julianne Szczepanski, MD, BSc, FCAP, Annette S. Kim, MD, PhD, FCAP, February 18, 2026
- Utility of Molecular Testing in the Diagnostic Workup of Difficult-to-Classify Tumors; Jie-Fu Chen, MD, FCAP, JinJuan Yao, MD, PhD, FCAP, January 21, 2026
- MET/c-MET: A Diagnostic Primer – Strategies in the Era of Targeted Therapies; Michael Barnes, MD, FCAP, Amita Mistry, MD, FCAP, December 3, 2025
- What’s New in Myelodysplastic Syndromes in Adults: ICC vs WHO5 and beyond; Chung-Che (Jeff) Chang, MD, PhD, FCAP, October 8, 2025
- Tissue Provenance: Personalized Health Care Starts with Analyzing the Correct Person; Jesse Cox, MD, PhD, FCAP, Allison Cushman-Vokoun, MD, PhD, FCAP, August 27, 2025
- Improvements on the Liquid Biopsy: Exosomes; Jordan Laser, MD, July 2025
- Immunohistochemical Surrogates of Molecular Genetic Alterations in Soft Tissue Tumors; Maria Del Carmen Rodriguez Pena, MD, Jason L. Hornick, MD, PhD, June 25, 2025
- CHIPping at inflammation; Marcello Pecoraro Toscano, MD, Genevieve M. Crane, MD, PhD, May 15, 2025
- Allogeneic Cellular Therapy – Diagnostic Challenges and Opportunities for Laboratory Practice; Fabienne Lucas, MD, PhD, FCAP, April 9, 2025
- Molecular Biomarkers in Salivary Gland Neoplasms; Gloria H. Sura, MD, FCAP, and Jessica S. Thomas, MD, PhD, MPH, FCAP, March 5, 2025
- DNA Methylation to the Rescue: An Update for Pathologists Navigating the Future of Precision Tumor Diagnostics; Matthew Hiemenz, MD, MS, FCAP and Justin Chang, MD, January 8, 2025
- Pathologists at the Forefront: Shaping the Future of Cancer Treatment with Molecular Tumor Boards;Â Michael Barnes, MD and Erin Cobain, MD, November 27, 2024
- Post-COVID-19 Blood Supply Challenges: Requests for Blood from Unvaccinated Donors; Kamran Urgun, MD and Gagan Mathur, MD, MBA, CPE, FCAP, October 30, 2024
- An Emerging Role of Pathologists in KRAS Mutation Testing and Targeted Treatment; Jinjuan Yao, MD, PhD, FCAP; Jing Wang, MD, September 30, 2024
- ESR1 Mutations in Hormone Receptor Positive Breast Cancer; Jordan Laser, MD, Aug 2, 2024
- BCL2-Rearrangement Negative Follicular Lymphomas: Oh No, Say It Ain’t So!; Annette S. Kim, MD, PhD, FCAP; Mark Girton, MD; Anup Jnawali, MD, July 17, 2024
- Homologous Recombination Repair Deficiency (HRD): Brief Review of the Clinical Implication and Methodology of Measurement; Katherine Gui; Chung-Che (Jeff) Chang, MD, PhD, May 29, 2024
- HER2/ERBB2 Testing in Colorectal Cancer; Joseph E. Willis, MD, FCAP, May 1, 2024
- HER2-Low Breast Carcinoma; Ronald Paler, MD, FCAP, April 3, 2024
- Emerging Family of Spindle Cell Neoplasms with Kinase Fusions; Esther Baranov, MD; Jason L. Hornick, MD, PhD, February 22, 2024
- Genetic Counselors: Your Partners in Laboratory Medicine;Â Jacquelyn D. Riley, MS, CGC, LGC; Matthew W. Anderson, MD, PhD, FCAP, January 17, 2024
- Advancements in Transfusion Medicine: Towards the Era of Universal Blood; Roksolana Demianets, MD, Sumayya Aslam, MD; Gagan Mathur, MD, MBA, CPE, FCAP, November 1, 2023
- Revolutionizing Inflammatory Bowel Disease Histology Assessment Through Artificial Intelligence; Eric Walk, MD, FCAP; Fedaa Najdawi, MD, FCAP, October 4, 2023
- Updates in Glioma and Meningioma Classification – WHO 2021 & New Entities in the Literature; Sahara Cathcart, MD, Allison Cushman-Vokoun, MD, PhD, September 13, 2023
- Molecular Diagnosis and Targeted Treatment of Pancreatic and Biliary Cancers;Â Jinjuan Yao, MD, PhD, FCAP, August 23, 2023
- Is it Magic? Artificial Intelligence Integration into Clinical Cytometry Workflows; Joshua Lewis, MD, PhD; Fabienne Lucas, MD, PhD; Chung-Che (Jeff) Chang, MD, PhD, July 5, 2023
- Pharmacogenetics: A Tool for Precision Medical Therapy; Bradley Grant, MD, JD; Jordan Laser, MD, June14, 2023
- Optical Genome Mapping: A ‘Tool’ with Significant Potential from Discovery to Diagnostics; Samuel Brody, MS; Adrian M. Dubuc, PhD, FACMG; Annette S. Kim, MD, PhD, FCAP, May 10, 2023
- What’s new in AML Classification (WHO 2022 vs International Consensus Classification); Chung-Che (Jeff) Chang, MD, PhD, FCAP and Amirah Kuzu, MD, March 29, 2023
- Phosphorylated Alpha-Synuclein in Assessment of Neurodegenerative Disease; Ronald Paler, MD, FCAP, January 11, 2023
- CAR T-Cells Therapies: Opportunities and Challenges;Â Valentina Zanfagnin, MD and Gagan Mathur, MD, MBA, CPE, FCAP, November 30, 2022
- Next Generation Anatomic Pathology: Innovative Imaging Technologies on the Horizon; Iny Jhun, MD, ScD; Eric Walk, MD, FCAP, October 5, 2022
- Genomic Alterations as Predictors of Immunotherapy Response;Â Jinjuan Yao, MD, PhD, FCAP, August 16, 2022
- Molecular Subclassifications of DLBCL; Annette S. Kim, MD, PhD, FCAP;Â Fabienne Lucas, MD, PhD, July 14, 2022
- Doing a Lot with a Little: Molecular Testing on Cytology Specimens;Â Annette S. Kim, MD, PhD, FCAP;Â Vladislav V. Makarenko, MD, PhD, June 28, 2022
- Biomarker Testing in Gastrointestinal Stromal Tumors (GIST);Â Chung-Che (Jeff) Chang, MD, PhD, FCAP, May 20, 2022
- Molecular Diagnostics in Sarcoma Pathology; Matthew Hiemenz, MD, MS, FCAP, March 31, 2022